Bladder preservation therapy with GC radiation against invasive bladder cancer.
Not Applicable
- Conditions
- Muscle-invasive bladder cancer
- Registration Number
- JPRN-UMIN000006363
- Lead Sponsor
- Department of Urology, Yamaguchi University, School of Medicine
- Brief Summary
Chemoradiotherapy using gemcitabine and cisplatin for muscle-invasive bladder cancer is effective for local cancer control and shows no significant difference in oncological prognosis compared with radical cystectomy.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 38
Inclusion Criteria
Not provided
Exclusion Criteria
1 Patients who have contraindication against gemcitabine and/or cisplatin. 2 Patients who received previous irradiation to pelvis. 3 Others, patients who have unsuitable condition.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Recurrence-free survival rate
- Secondary Outcome Measures
Name Time Method Disease-specific survival rate Overall survival rate Incidence of adverse events